In a report released on July 9, Ben Hendrix from RBC Capital maintained a Buy rating on HCA Healthcare, with a price target of $534.00. The company’s shares closed yesterday at $409.01.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Hendrix covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Sonida Senior Living, and CVS Health. According to TipRanks, Hendrix has an average return of 8.8% and a 56.40% success rate on recommended stocks.
In addition to RBC Capital, HCA Healthcare also received a Buy from Bank of America Securities’s Kevin Fischbeck in a report issued on July 8. However, on the same day, Barclays downgraded HCA Healthcare (NYSE: HCA) to a Hold.
Based on HCA Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $19.11 billion and a net profit of $1.62 billion. In comparison, last year the company earned a revenue of $18.32 billion and had a net profit of $1.61 billion
